Ping An Biomedical Co., Ltd. (PASW) - Net Assets
Based on the latest financial reports, Ping An Biomedical Co., Ltd. (PASW) has net assets worth $45.24 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($68.41 Million) and total liabilities ($23.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Ping An Biomedical Co., Ltd. balance sheet liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $45.24 Million |
| % of Total Assets | 66.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ping An Biomedical Co., Ltd. - Net Assets Trend (2021–2025)
This chart illustrates how Ping An Biomedical Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore Ping An Biomedical Co., Ltd. (PASW) total assets for the complete picture of this company's asset base.
Annual Net Assets for Ping An Biomedical Co., Ltd. (2021–2025)
The table below shows the annual net assets of Ping An Biomedical Co., Ltd. from 2021 to 2025. For live valuation and market cap data, see Ping An Biomedical Co., Ltd. market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $45.24 Million | +729.39% |
| 2024-09-30 | $-7.19 Million | -22.67% |
| 2023-09-30 | $-5.86 Million | -227.40% |
| 2022-09-30 | $4.60 Million | +323.00% |
| 2021-09-30 | $-2.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ping An Biomedical Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1897784300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $66.29 Million | 146.52% |
| Total Equity | $45.24 Million | 100.00% |
Ping An Biomedical Co., Ltd. Competitors by Market Cap
The table below lists competitors of Ping An Biomedical Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Globlex Holding Management Public Company Limited
BK:GBX
|
$18.33 Million |
|
TryHard Holdings Limited Ordinary Shares
NASDAQ:THH
|
$18.33 Million |
|
Rma Global Ltd
AU:RMY
|
$18.33 Million |
|
Barrel Co. Ltd
KQ:267790
|
$18.34 Million |
|
SAF Tehnika A/S
F:VTZ
|
$18.30 Million |
|
BLUELAKE MINERAL AB
F:5KG0
|
$18.29 Million |
|
Vitura Health Ltd
AU:VIT
|
$18.29 Million |
|
IXUP Ltd
AU:IXU
|
$18.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ping An Biomedical Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -7,188,181 to 45,242,007, a change of 52,430,188.
- Net loss of 12,829,206 reduced equity.
- New share issuances of 108,187,500 increased equity.
- Other comprehensive income decreased equity by 1,022,758.
- Other factors decreased equity by 41,905,348.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.83 Million | -28.36% |
| Share Issuances | $108.19 Million | +239.13% |
| Other Comprehensive Income | $-1.02 Million | -2.26% |
| Other Changes | $-41.91 Million | -92.62% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Ping An Biomedical Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.07x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-09-30 | $-0.15 | $0.16 | x |
| 2022-09-30 | $0.22 | $0.16 | x |
| 2023-09-30 | $-0.29 | $0.16 | x |
| 2024-09-30 | $-0.35 | $0.16 | x |
| 2025-09-30 | $2.21 | $0.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ping An Biomedical Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -28.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -37.57%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 1.51x
- Recent ROE (-28.36%) is below the historical average (25.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 5.24% | 1.35x | 0.00x | $5.42 Million |
| 2022 | 157.12% | 6.31% | 1.40x | 17.82x | $6.77 Million |
| 2023 | 0.00% | -1.20% | 1.03x | 0.00x | $-407.98K |
| 2024 | 0.00% | -1.47% | 1.54x | 0.00x | $-565.35K |
| 2025 | -28.36% | -37.57% | 0.50x | 1.51x | $-17.35 Million |
Industry Comparison
This section compares Ping An Biomedical Co., Ltd.'s net assets metrics with peer companies in the Textile Manufacturing industry.
Industry Context
- Industry: Textile Manufacturing
- Average net assets among peers: $318,348,200
- Average return on equity (ROE) among peers: 1.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ping An Biomedical Co., Ltd. (PASW) | $45.24 Million | 0.00% | 0.51x | $18.31 Million |
| Albany International Corporation (AIN) | $877.61 Million | 13.50% | 0.77x | $1.67 Billion |
| Culp, Inc. Common Stock (CULP) | $103.39 Million | 6.98% | 0.87x | $35.84 Million |
| Culp, Inc. Common Stock (CULP) | $119.50 Million | -2.69% | 0.49x | $34.82 Million |
| The Dixie Group Inc (DXYN) | $108.29 Million | -8.61% | 2.91x | $4.33 Million |
| Unifi Inc (UFI) | $382.95 Million | -3.75% | 0.91x | $67.08 Million |
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finish… Read more